Doctors are not safe with some patients.

Published Date: 16 Feb 2023

Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.

Read Full News

Latest News

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

Health news and commentary gathered by MedPage Today staff

FDA Approves Novel Treatment for UTIs

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Mission Health Urologists Disappear.

Following the takeover by HCA, experts identify the most recent departures.

More then ever, the healthcare industry needs qualified expert witnesses.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

The medication used to treat sexual desire disorder in women also helps men.

Melanoside is associated with several beneficial effects on male sexual function.

Combination Treatments for Erectile Dysfunction: Uneven Outcomes.

When treating severe ED, one combination worked well; when treating milder ED, it did not.

Todays Updates

NLX-112 Shows Safety and Tolerability in Phase 2a Parkinson Trial, Supporting Further Development Louie Pasculli

A phase 2a trial showed that NLX-112 was safe and well tolerated in patients with Parkinson disease, while also reducing levodopa-induced dyskinesia and motor symptoms, supporting further clinical development.

AskBio’s Late-Onset Pompe Disease Gene Therapy AB-1009 Cleared for Phase 1/2 Trial Noah Stansfield

AskBio noted that AB-1009 also recently received fast track and orphan drug designations from the FDA.

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

Todays Updates

NLX-112 Shows Safety and Tolerability in Phase 2a Parkinson Trial, Supporting Further Development Louie Pasculli

A phase 2a trial showed that NLX-112 was safe and well tolerated in patients with Parkinson disease, while also reducing levodopa-induced dyskinesia and motor symptoms, supporting further clinical development.

AskBio’s Late-Onset Pompe Disease Gene Therapy AB-1009 Cleared for Phase 1/2 Trial Noah Stansfield

AskBio noted that AB-1009 also recently received fast track and orphan drug designations from the FDA.

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

Latest News

Health news and commentary gathered by MedPage Today staff

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Following the takeover by HCA, experts identify the most recent departures.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

Melanoside is associated with several beneficial effects on male sexual function.

When treating severe ED, one combination worked well; when treating milder ED, it did not.

News All Time

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

It is necessary to intervene at several stages of the cancer immunity cycle in order to build on recent successes.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Dietary inflammation is associated with the development of urologic cancers.

In health research, the relationship between dietary habits and cancer risks is still a major focus. The has been the subject of a recent meta-analysis.

In infants, laparoscopic robotic pyeloplasty is safe and has a success rate comparable to open surgery.

The results of minimally invasive pyeloplasty (MIP) for the primary cause, ureteropelvic junction obstruction (UPJO), were examined in a recent study.

Medical Bulletin November 30, 2023.

The top medical stories of the day are as follows: ADHD increases the risk of car crashes in older adults. ADHD is a neurodevelopmental disorder that is chronic and has symptoms.

The only viable solution for stress urinary incontinence with mesh slings is informed decision-making.

UK: A recent study thoroughly examined the short- and long-term mesh sling complications reported in European Urology Focus.

Black people who consume a few servings of whole grains have been shown to experience a slower rate of memory loss.

A slower rate of memory loss may be experienced by Black individuals who consume more whole grain-containing foods, such as popcorn, quinoa, and some breads and cereals.

Wellness Bulletin 25/November/2023.

Here are the top health stories for the day:Doctors performing 'Two Finger Test' will be guilty of misconductReiterating the fact that the Supreme.

Do Patients Follow Up on Recommended Care Following Telehealth Visits?

Experts offer tips for improving compliance after telehealth visits. How many patients follow through on your recommendations after they've finished their visit? Does it matter whether you saw them virtually or in person?

Details of the MCC withdrawal of two MCh Urology seats from the Round 1 NEET SS Counseling Seat Matrix are provided.

New Delhi: MCH Urology's seats in Round 1 NEET have been withdrawn, as announced by the Medical Counselling Committee (MCC) in a recent notice.

Recommended News For You

a brand-new generic therapy for different types of cancer.

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

Biomarker panel offers hope for early pancreatic cancer detection

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

Recommended Articles For You

AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency 

Polyposis Syndrome: Causes, Symptoms, and Treatment Options 

Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response 

Elevating Hematology Oncology: Modern Approaches for Smarter Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Healthcare in the Mix in President Biden's Farewell Address

2.

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

3.

Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

4.

Many Americans unaware of links between HPV and cancers, poll reveals

5.

Ineffective medication can remove the "worst fear" of schizophrenia.

1.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

2.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

3.

Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?

4.

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment

5.

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

5.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot